Insiders Compugen Ltd. TEL AVIV STOCK EXCHANGE

Equities

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 09:28:50 07/07/2024 BST			5-day change	1st Jan Change
582.2 ^ILa	-8.53%		-9.30%	-15.38%

06-27	Transcript : Compugen Ltd. - Special Call
05-30	Compugen Ltd. to Receive Milestone Payment from Astrazeneca Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig	CI

Compugen Names David Silberman CFO	05-15	MT
Compugen Ltd. Announces Executive Changes	02-15	CI
Compugen Names Alberto Sessa CFO	12/09/22	MT
Compugen Ltd. Announces Resignation of Ari Krashin as Chief Operating Officer in August 2022	04/08/22	CI
Compugen Ltd. Announces Resignation of Ari Krashin as Chief Financial Officer in August 2022	04/08/22	CI
Compugen CFO, COO Ari Krashin to Step Down in August	10/05/22	MT
Compugen Announces Ari Krashin Departure as Chief Operating Officer	10/05/22	CI
Compugen Ltd. Announces Board Changes	24/02/22	CI
Compugen Ltd. Announces Board Changes	30/09/20	CI
Compugen Ltd. Announces Appointment of Oliver Froescheis as Senior Vice President, Corporate and Business Development	08/01/20	CI
Compugen Ltd. Announces Board Changes	02/07/19	CI
Compugen Ltd. Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors	05/09/18	CI
Compugen Ltd. Announces Board Changes	11/06/18	CI
Dov Hershberg Resigns as Director of Compugen Ltd	04/06/18	CI
Compugen Ltd. Appoints Henry Adewoye as Chief Medical Officer	26/03/18	CI
Compugen Ltd. Announces Management Changes	31/01/18	CI
Joshua Shemer Resigns as Director of Compugen Ltd	18/12/17	CI
Compugen Ltd. Appoints Paul Sekhri as Director and Chairman of the Board, Effective October 2, 2017	02/08/17	CI
Compugen Ltd Appoints Michal Preminger to Board of Directors	25/05/17	CI
Compugen Adds Miriam Merad to Scientific Advisory Board	08/03/17	CI

No results for this search